TRELLUS HEALTH PLC
Get an alert when TRELLUS HEALTH PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-28 (in 2mo)
Last made up 2025-07-14
Watchouts
Cash
£3M
USD 4,344,000
-64.3% vs 2023
Net assets
—
Equity attributable
Employees
18
-5.3% vs 2023
Profit before tax
-£6M
USD -7,782,000
-22.8% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Outstanding charges registered
One or more mortgages or charges remain undischarged on the Companies House register.
-
Material uncertainty over going concern
The directors believe that additional funding can be obtained to enable the Company and the Group to continue in existence for a period of at least 12 months at the date of approval of these financial statements. However, there is no guarantee that sufficient cash inflows from partnerships, equity fundraising or other sources will be forthcoming in the timeframe required. This represents a material uncertainty in relation to the funding arrangements of the Group which may result in the Company and the Group not being a going concern.
Profit before tax
2-year trend · vs Technology median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £14,203 | £85,221 | |
| Operating profit | -£5,085,595 | -£6,000,598 | |
| Profit before tax | -£4,738,731 | -£5,817,448 | |
| Net profit | -£4,738,731 | -£5,817,448 | |
| Cash | £9,094,715 | £3,247,365 | |
| Total assets less current liabilities | — | — | |
| Net assets | — | — | |
| Equity | £14,578,007 | £8,796,442 | |
| Average employees | 19 | 18 | |
| Wages | £2,590,267 | £2,629,887 | |
| Directors' remuneration | £300,362 | £292,457 |
Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+500%
£14,203 £85,221
-
Cash
-64.3%
£9,094,715 £3,247,365
-
Net assets
—
Not reported
-
Employees
-5.3%
19 18
-
Operating profit
-18%
-£5,085,595 -£6,000,598
-
Profit before tax
-22.8%
-£4,738,731 -£5,817,448
-
Wages
+1.5%
£2,590,267 £2,629,887
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 15.69x | 12.15x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- TRELLUS HEALTH PLC 2021-05-12 → present
- TRELLUS HEALTH LIMITED 2020-07-15 → 2021-05-12
Audit & accounting basis
- Accounting basis
- UK-adopted International Accounting Standards
- Reporting scope
- Consolidated group
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors believe that additional funding can be obtained to enable the Company and the Group to continue in existence for a period of at least 12 months at the date of approval of these financial statements. However, there is no guarantee that sufficient cash inflows from partnerships, equity fundraising or other sources will be forthcoming in the timeframe required. This represents a material uncertainty in relation to the funding arrangements of the Group which may result in the Company and the Group not being a going concern.”
Group structure
- TRELLUS HEALTH PLC · parent
- Trellus Health Inc 100%
Significant events
- “Post-period, in January 2025, we announced a key commercial milestone: a pilot agreement with Johnson & Johnson Health Care Systems Inc. ("J&J"). This one-year collaboration will evaluate the Trellus Elevate® program's impact on supporting individuals with moderately to severely active IBD who are prescribed a J&J therapy in the U.S.”
- “During December 2024, the company received an employment tribunal claim for the underpayment of notice pay (and pension contributions), underpayment of accrues unused holiday pay, unfair dismissal, failure to provide a statement of employment terms and failure to provide a written reason for dismissal. The total sum claimed is not particularised but is subject to a statutory cap of approximately £60,000 ($75,000). The company is defending the claim and it is disputed on a number of jurisdictional and factual grounds.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ONE ADVISORY LIMITED | Corporate Secretary | 2024-09-01 | — | — |
| DUBINSKY, Marla, Dr | Director | 2020-07-15 | Jul 1967 | American |
| ENTEL, Traci | Director | 2022-06-22 | Feb 1976 | American |
| GRIFFIN, Brian Thomas | Director | 2024-09-19 | Mar 1959 | American |
| LIUM, Erik Kristian, Dr | Director | 2020-07-15 | Mar 1968 | American |
| MURPHY, Kevin | Director | 2024-06-07 | May 1960 | American |
| SALTER, David Michael | Director | 2020-07-15 | Aug 1961 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAMIR, Salim | Secretary | 2020-07-17 | 2024-09-01 |
| BAINES, Julian Huw | Director | 2020-07-15 | 2023-02-06 |
| FAYAD, Monyc Pauline | Director | 2020-07-15 | 2022-07-19 |
| GANDHI, Niyum | Director | 2020-07-15 | 2021-12-31 |
| MAHONY, Daniel, Dr | Director | 2021-03-17 | 2024-06-14 |
| MILLS, Christopher Harwood Bernard | Director | 2021-03-22 | 2024-02-28 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ekf Diagnostics Holdings Plc | Corporate entity | Voting 25–50% | 2020-08-20 | Ceased 2020-12-18 |
| Icahn School Of Medicine At Mount Sinai | Corporate entity | Shares 25–50% | 2020-07-15 | Ceased 2020-07-15 |
Filing timeline
Last 20 of 64 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-01-27 RESOLUTIONS Resolution
- 2025-07-04 RESOLUTIONS Resolution
- 2024-07-03 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-07 | SH01 | capital | Capital allotment shares | |
| 2026-04-08 | SH01 | capital | Capital allotment shares | |
| 2026-03-02 | SH01 | capital | Capital allotment shares | |
| 2026-02-20 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2026-02-20 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-02-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2026-01-27 | RESOLUTIONS | resolution | Resolution | |
| 2025-07-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-04 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-09 | AA | accounts | Accounts with accounts type group | |
| 2025-02-17 | CH01 | officers | Change person director company with change date | |
| 2025-02-17 | CH01 | officers | Change person director company with change date | |
| 2024-12-27 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-09-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-09-02 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2024-07-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-03 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-01 | AA | accounts | Accounts with accounts type group | |
| 2024-06-29 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.